Related Experiment Videos
Molecular cloning of human dectin-2
The Journal of Investigative Dermatology
|June 4, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A case of glucocorticoid-resistant VEXAS syndrome successfully treated with baricitinib.
Modern rheumatology case reports·2026
Cornering: A Geometric Framework for Surgical Dissection in Minimally Invasive Surgery.
Surgical innovation·2026
Proteomic Profiling Reveals HECTD4-dependent Regulation of Protein Ubiquitination and Signaling Pathways in Prostate Cancer.
Cancer genomics & proteomics·2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.
Annals of the rheumatic diseases·2026
Mapping the global work-related impact of immune-mediated inflammatory skin diseases: a systematic review.
The Journal of investigative dermatology·2026
Lipase GehA functions as a positive-feedback amplifier of Cutibacterium acnes-sebum interactions in acne pathogenesis.
The Journal of investigative dermatology·2026
Disease context dictates the cellular targets of IL-17 in inflammatory skin disease.
The Journal of investigative dermatology·2026
Self-antigen keratin 17 presented by keratinocytes promotes T cell auto-reactivity in psoriasis.
The Journal of investigative dermatology·2026
Psoriasis-risk SNP rs610604 reveals nuclear IKKα-TNFAIP3 repressor axis driving autoinflammatory circuits.
The Journal of investigative dermatology·2026
Updates on endothelial injury in dermatomyositis: Clinical correlations and potential mechanisms.
The Journal of investigative dermatology·2026
Phthalocyanine conjugates with nucleosides and nucleic acids: synthetic strategies, photophysical properties, and biomedical applications.
Organic & biomolecular chemistry·2026
Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications.
Frontiers in immunology·2026
Ubiquitin family as novel protein partners for molecular glues.
npj drug discovery·2026